Showing results (1-10 of 1,928) with videos related to

Sort By:
Pageof 193
Hematology. American Society of Hematology. Education Program|December 9, 2022
What have we learned about the patient's experience of von Willebrand disease? A focus on womenHeather VanderMeulen, Sumedha Arya, Sarah Nersesian, et al.
Hematology. American Society of Hematology. Education Program|December 9, 2022
Diagnostic pitfalls and conundrums in type 1 von Willebrand diseaseRobert F Sidonio, Michelle Lavin
Hematology. American Society of Hematology. Education Program|December 9, 2022
Optimal approach to T-cell ALLKristen M O'Dwyer
Hematology. American Society of Hematology. Education Program|December 9, 2022
Achieving MRD negativity in AML: how important is this and how do we get there?Christopher S Hourigan
Hematology. American Society of Hematology. Education Program|December 9, 2022
Beyond the cell: novel noncellular immunotherapy approaches to multiple myelomaSarah A Holstein
Hematology. American Society of Hematology. Education Program|December 9, 2022
Do all patients with primary refractory/first relapse of HL need autologous stem cell transplant?Alison J Moskowitz
Hematology. American Society of Hematology. Education Program|December 9, 2022
Hitting the brakes on accelerated and blast-phase myeloproliferative neoplasms: current and emerging conceptsJan Philipp Bewersdorf, Raajit K Rampal
Hematology. American Society of Hematology. Education Program|December 9, 2022
Knowledge to date on secondary malignancy following hematopoietic cell transplantation for sickle cell diseaseCourtney D Fitzhugh
Hematology. American Society of Hematology. Education Program|December 9, 2022
Organ function indications and potential improvements following curative therapy for sickle cell diseaseMonica L Hulbert, Allison A King, Shalini Shenoy
Pageof 193